Skip to content

Clinical trials

Neoplasm Metastasis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: United States Clear all

1,976 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200019
200129
200224
200336
200452
200566
200673
200765
200863
200980
201071
201176
201272
201378
201479
201552
201674
201777
201869
201986
202083
2021133
2022101
202398
202475
202581
202676

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed948
Terminated398
Recruiting287
Active, not recruiting186
Unknown status57
Withdrawn55
Not yet recruiting25
Suspended13
No longer available2
Enrolling by invitation2
Approved for marketing2
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)119
M.D. Anderson Cancer Center118
Eli Lilly and Company53
Memorial Sloan Kettering Cancer Center51
Pfizer34
AstraZeneca33
H. Lee Moffitt Cancer Center and Research Institute30
Novartis Pharmaceuticals29
Dana-Farber Cancer Institute22
Massachusetts General Hospital21

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis1,976
Neoplasms411
Breast Neoplasms307
Carcinoma, Non-Small-Cell Lung242
Colorectal Neoplasms230
Melanoma205
Lung Neoplasms171
Prostatic Neoplasms155
Pancreatic Neoplasms144
Recurrence134

Trials

Showing 1 to 25 of 1,976. Each trial links to its page on Pharma Observatory.

1,876 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.